2,4-di-tert-butyl-6-methyl-anisole | 21573-44-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2,4-di-tert-butyl-6-methyl-anisole
• 英文别名: 2,4-Di-tert-butyl-6-methyl-anisol；1,5-Ditert-butyl-2-methoxy-3-methylbenzene
• CAS: 21573-44-4
• 化学式: C₁₆H₂₆O
• 分子量: 234.382
• InChiKey: IIETZAXEVCSLLS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.62
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2,4-di-tert-butyl-6-methyl-anisole 在 manganese(IV) oxide 、 硫酸 作用下， 生成 3,5-二-叔丁基-2-甲氧基苯甲醛
  参考文献：
  名称：

  NITRO MUSKS. I. ISOMERS, HOMOLOGS, AND ANALOGS OF MUSK AMBRETTE

  摘要：

  DOI：

  10.1021/jo01144a011
• 作为产物：
  描述：

  硫酸二甲酯 、 alkaline earth salt of/the/ methylsulfuric acid 在 甲苯 作用下， 生成 2,4-di-tert-butyl-6-methyl-anisole
  参考文献：
  名称：

  NITRO MUSKS. I. ISOMERS, HOMOLOGS, AND ANALOGS OF MUSK AMBRETTE

  摘要：

  DOI：

  10.1021/jo01144a011

文献信息

• Cytokine Inhibitors
  申请人：Aungst Ronald A.

  公开号：US20090023701A1

  公开（公告）日：2009-01-22

  Disclosed are compounds of formula (I) which inhibit production of cytokines involved in inflammatory processes and are thus useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease. Also disclosed are processes for preparing these compounds and pharmaceutical compositions comprising these compounds.

  公开了化合物(I)的公式，这些化合物抑制了涉及炎症过程的细胞因子的产生，因此可用于治疗涉及炎症的疾病和病理条件，如慢性炎症性疾病。还公开了制备这些化合物的过程以及包含这些化合物的制药组合物。
• Quinoline copolymer and organic electroluminescent device employing same
  申请人：Morishita Yoshii

  公开号：US20070003783A1

  公开（公告）日：2007-01-04

  The present invention relates to a quinoline copolymer containing an optionally substituted quinoline monomer unit and an optionally substituted benzotriazole monomer unit. It is an object of the present invention to provide a light-emitting polymer material having excellent stability.
• ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES
  申请人：Universal Display Corporation

  公开号：US20220085302A1

  公开（公告）日：2022-03-17

  A compound having a ligand L A of Formula I, is disclosed. In Formula I, ring B is a 5-membered or 6-membered ring; K is a direct bond, O, or S; X is O, S, Se, NR, CRR′, SiRR′, or GeRR′; R 1 and R 2 are each independently selected from a variety of substituents; each R, R′, R A , and R B is independently hydrogen or a substituent; L A is coordinated to a metal M selected from Os, Ir, Pd, Pt, Cu, Ag, or Au by the dashed lines; any two adjacent of R 1 , R 2 , R, R′, R A , or R B can be joined or fused to form a ring, with the proviso that when ring B is a 6-membered ring, two R B substituents are not joined to form a fused 6-membered aromatic ring. Organic light emitting devices, consumer products, formulations, and chemical structures containing the compounds are also disclosed.
• US7285545B2
  申请人：——

  公开号：US7285545B2

  公开（公告）日：2007-10-23
• US7470692B2
  申请人：——

  公开号：US7470692B2

  公开（公告）日：2008-12-30